Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Noriaki Iwase
Observed names:
Iwase, Noriaki,
Noriaki IWASE
Institution:
Ube (Japan)
Observed institutions:
Broad Institute,
Tokyo Institute of Technology,
Harvard University,
Massachusetts General Hospital,
Massachusetts Institute of Technology,
Ube (Japan)
show all 6
OpenAlex ID:
A5070917621
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
2012
·
Sarah A. Stanley
, Sarah Schmidt Grant
, et al.
·
ACS Chemical Biology
·
269
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
2013
·
Sarah A. Stanley
, Tomohiko Kawate
, et al.
·
Proceedings of the National Academy of Sciences
·
109
Synthesis and structure–activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32
2013
·
Tomohiko Kawate
, Noriaki Iwase
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
68
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors
2016
·
Sarah Schmidt Grant
, Samantha Wellington
, et al.
·
Cell chemical biology
·
67
PDF
Substrate Specificity of 2-Deoxy-scyllo-inosose Synthase, the Starter Enzyme for 2-Deoxystreptamine Biosynthesis, toward Deoxyglucose-6-phosphates and Proposed Mechanism
1998
·
Noriaki IWASE
, Fumitaka KUDO
, et al.
·
Bioscience Biotechnology and Biochemistry
·
23
Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference
2023
·
Soichiro Ide
, Noriaki Iwase
, et al.
·
International Journal of Molecular Sciences
·
7
PDF
Novel Oral Derivative UD-017, a Highly Selective CDK7 Inhibitor, Exhibits Anticancer Activity by Inducing Cell- Cycle Arrest and Apoptosis in Human Colorectal Cancer
2020
·
Yasuhiro Aga
, Takashi Matsushita
, et al.
·
Hiroshima journal of medical sciences
·
3
Abstract 4837: Evaluation of anticancer activities of UD-017, a novel selective and orally available CDK7 inhibitor, in blood cancers
2018
·
Yasuhiro Aga
, Sayaka Ogi
, et al.
·
Cancer Research
·
3
Abstract LB-111: In vitro anti-cancer activity of UD-017, a novel potent & highly selective CDK7 reversible inhibitor
2017
·
Takashi Matsushita
, Kazuhiro Onuma
, et al.
·
Cancer Research
·
3
Preclinical evaluation of HL001, a novel lysophosphatidic acid 1 (LPA1) receptor antagonist, for idiopathic pulmonary fibrosis utilizing physiologically relevant stem cell-derived lung organoids
2023
·
Yuki Yamamoto
, Tetsuharu Nagamoto
, et al.
·
European Respiratory Journal
·
2
Inhibitory effects of the selective μ‐opioid receptor antagonist UD ‐030 on methamphetamine‐induced conditioned place preference
2024
·
Soichiro Ide
, Noriaki Iwase
, et al.
·
Neuropsychopharmacology Reports
·
1
PDF
Inhibitory effects of the novel μ-opioid receptor non-peptide antagonist, UD-030, on the morphine-conditioned place preference
2023
·
Soichiro Ide
, Noriaki Iwase
, et al.
·
Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Preclinical in vitro and in vivo evaluation of antitumor activity of UD-017, a novel selective and orally available CDK7 inhibitor, in colorectal cancer.
2017
·
Sayaka Ogi
, Yasuhiro Aga
, et al.
·
Journal of Clinical Oncology
Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model
2016
·
Kenji Nishikawa
, Eiji Okanari
, et al.
·
European Respiratory Journal
Elucidation of the physiology of non-replicating, drug tolerant Mycobacterium tuberculosis with the aid of the small molecule probe ML338
2013
·
Partha P. Nag
, Sarah Schmidt Grant
, et al.
CCDC 940704: Experimental Crystal Structure Determination
2013
·
Stanley, Sarah A.
, Kawate, Tomohiko
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
16
Citation count:
555
H-index:
6
I10-index:
5
Year
Topic
Type